The presence of excess weight or obesity in long COVID is significantly associated with neurological and neuropsychiatric symptom development.

The FDA has approved Sephience for the treatment of HPA in adult and pediatric patients 1 month of age and older with sepiapterin-responsive PKU.

Adolescents who use tobacco products are significantly more likely to report symptoms of depression and anxiety than teens who do not use tobacco products.

Among patients with T2D and DPN, some with nonpainful DPN developed neuropathic pain over a 5-year period while others with painful DPN experienced relief.

Individuals with social risk factors at the time of SARS-CoV-2 infection have increased risk for subsequent long COVID.

(HealthDay News) — Women with multiple sclerosis (MS) are less likely to receive disease-modifying therapies (DMTs) than men, according to a study published online July 30 in Neurology.

HealthDay News — Intranasal administration of [ 68 Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23 in Alzheimer’s & Dementia: ...

Lifetime risk for dementia is higher among women, Black adults, and APOE ε4 allele carriers, with the number of new cases expected to rise over the next 4 decades.

Dementia with Lewy bodies (DLB), the second most common type of dementia, requires a multifactorial approach to reduce symptoms.

The Food and Drug Administration has granted Fast Track designation to PMN310 for the treatment of Alzheimer disease.

The structured intervention benefit was consistent for APOE ε4 carriers and noncarriers but seemed greater for adults with lower vs higher baseline cognition.

Screening for emotional and cognitive issues after ischemic stroke does not improve societal participation at 1 year.